NOTE to EDITORS: EVs remain a novelty in the automotive space, accounting for less than 2% of global vehicle sales, but demand is increasing and expected to grow from slightly over 1 million vehicles in 2017 to 11 million vehicles by 2025, according to a recent report by BloombergNEF.

PHTHALATES FACTS PHTHALATES ARE KNOWN TO BREAK DOWN IN THE HUMAN BODY Research has shown that after entering the body, phthalate are broken down into metabolites within minutes and pass out quickly in urine.2 PHTHALATE EXPOSURE IS CONSIDERED LOW Despite the fact that phthalates are used in a wide range of products, human exposure from all sources is considered to be extremely low.2 PHTHALATES ARE A USEFUL CHOICE FOR HEALTHCARE Flexible vinyl tubing does not react with most medications, allowing for reliable administration of drugs, while flexible vinyl bags prevent blood contamination and extend shelf life of the blood.3 PHTHALATES ARE REGULATED Based on earlier studies, a few specific phthalates have been banned for use in toys or other items for sale to children under twelve to reduce risk of overexposure through hand-to- mouth behaviors. 1 Source: chemicalsafetyfacts.org 2 Source: Centers for Disease Control and Prevention 3 Source: thisisplastics.com www.avient.com Copyright © 2020, Avient Corporation.

For and on behalf of BSI: Carlos Pitanga, Chief Operating Officer Assurance – Americas Certification Date: 2018-07-11 Latest Issue: 2018-07-11 Expiry Date: 2021-07-10 BSI Certificate Number: 85585 IATF Number: 0315491 Page: 1 of 2 This certificate remains the property of BSI and shall be returned immediately upon request. Including the following remote support functions: Polyone Corporation 33587 Walker Road Avon Lake, OH 44012 USA Audited by ABS Quality evaluations Product Design, Purchasing, Customer Service and Strategic Planning Location Registered Activities BSI Certificate Number: 85585 IATF Number: 0315491 Certification Date: 2018-07-11 Latest Issue: 2018-07-11 Expiry Date: 2021-07-10 Page: 2 of 2 This certificate remains the property of BSI and shall be returned immediately upon request.

Chicago, Illinois 2. NOx: 0.09 MT 2. PSIC: 0 2.

Patterson 2/10/2020 — — — — — 59,071 1,994,237 — — 2/08/2021 — — — — — 46,178 1,558,969 — — 2/14/2022 — — — — — 39,116 1,320,556 — — 5/15/2014 — — — — — — — 58,845 1,986,607 2/14/2018 31,516 — — 41.89 2/14/2028 — — — — 2/11/2019 51,150 — — 31.54 2/11/2029 — — — — 2/10/2020 57,516 57,517 — 31.48 2/10/2030 — — — — 2/08/2021 59,233 118,467 — 42.27 2/08/2031 — — — — 2/14/2022 — — 134,700 52.64 2/14/2032 — — — — J.A. Garratt 2/10/2020 — — — — — 6,764 228,353 — — 2/08/2021 — — — — — 5,274 178,050 — — 2/14/2022 — — — — — 4,667 157,558 — — 2/04/2015 9,200 — — 38.27 2/4/2025 — — — — 2/15/2017 13,250 — — 34.10 2/15/2027 — — — — 2/14/2018 11,050 — — 41.89 2/14/2028 — — — — 2/11/2019 18,200 — — 31.54 2/11/2029 — — — — 2/10/2020 13,100 6,550 — 31.48 2/10/2030 — — — — 2/08/2021 6,716 13,434 — 42.27 2/08/2031 — — — — 2/14/2022 — — 16,000 52.64 2/14/2032 — — — — L.K. Kunkle 2/20/2020 — — — — — 7,302 246,516 — — 2/08/2021 — — — — — 5,639 190,373 — — 2/14/2022 — — — — — 5,282 178,320 — — 2/15/2017 12,100 — — 34.10 2/15/2027 — — — — 2/14/2018 11,500 — — 41.89 2/14/2028 — — — — 2/11/2019 19,250 — — 31.54 2/11/2029 — — — — 2/10/2020 14,133 7,067 — 31.48 2/10/2030 — — — — 2/08/2021 7,216 14,434 — 42.27 2/08/2031 — — — — 2/14/2022 — — 18,050 52.64 2/14/2032 — — — — J.R.

The number shown on this form is my correct taxpayer identification number (or I am waiting for a number to be issued to me); and 2. You must cross out item 2 above if you have been notified by the IRS that you are currently subject to backup withholding because you have failed to report all interest and dividends on your tax return. For real estate transactions, item 2 does not apply.

Autoinjector Pen - Avient Application Study.mm (1) AUTO-INJECTOR APPLICATION STUDY M A T E R I A L T E C H N O L O G I E S + S E R V I C E S F O R N E X T G E N E R A T I O N D E S I G N S Avient Corporation 1 Avient Corporation 2 Innovating Design Medical innovations and plastics have gone hand-in-hand to make healthcare safer, cleaner, and more accessible for all. We can help tackle your toughest challenges with our • In-depth industry knowledge • Expansive material solutions • Far-reaching technical capabilities and services Avient Corporation 4 1 Injection window Integrated rigid needle shield 2 Cap 3 1. Requirements: Excellent clarity, scratch resistance and exceptional toughness for visualization of medicant levels Solution: Avient Distribution HC Portfolio: Acrylic, copolyester, PC 2.

Slide 1 PolyOne Corporation Page 1 PolyOne Investor Presentation Bank of America Merrill Lynch 2014 US Basic Materials Conference Boston, MA December 11, 2014 PolyOne Corporation Page 2 Forward-Looking Statements  In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.9% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions -- 7.6% 8 – 10% Performance Products & Solutions 5.5% 8.1% 9 – 12% Distribution 2.6% 6.2% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 10.6% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 32% Adjusted EPS CAGR from 2011 2015 EPS: $2.50 2011 EPS: $0.82 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue Growth PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 31% 2006 2013 Specialty Platform Gross Margin % 20% 43% 2006 2013 Specialty Vitality Index Target ≥ 35% Vitality Products + 700 to 1000 bps PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of September 30, 2014 Debt Maturities & Pension Funding – 9/30/14 Net Debt / EBITDA* = 1.7x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of September 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 9/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.5 million shares in Q3 2014 Repurchased 9.7 million shares since early 2013  10.3 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? Platform operating income mix percentage 2005Y* 2008Y* 2010Y* 2013Y Q3 2014 YTD Global Color, Additives and Inks $ 4.3 $ 28.1 $ 37.7 $ 104.0 $ 98.2 Global Specialty Engineered Materials 0.4 17.6 49.7 57.2 55.6 Designed Structures and Solutions - - - 33.4 37.2 Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 194.6 $ 191.0 Performance Products and Solutions 75.7 31.3 54.0 56.0 51.4 Distribution 19.5 28.1 42.0 63.3 53.2 Joint ventures 91.9 28.6 18.9 - - Corporate and eliminations (51.5) (425.1) (27.7) (82.4) (126.2) Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 231.5 $ 169.4 Less: Corporate operating expense 51.5 425.1 27.7 82.4 126.2 Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 313.9 $ 295.6 Specialty platform operating mix percentage 2% 34% 43% 62% 65% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.

PCC has fewer impurities than GCC and can be produced in specific particle shapes, narrow particle size distributions, and fine particle sizes.2   Fumed synthetic silica is used for reinforcement and for infrared-light absorption in greenhouse films.2 The filler is also nonabrasive and has a low density.2 Aluminum oxide and nitride are more abrasive.

TÍTULO DO ESTABELECIMENTO (NOME DE FANTASIA) ******** PORTE DEMAIS CÓDIGO E DESCRIÇÃO DA ATIVIDADE ECONÔMICA PRINCIPAL 20.99-1-99 - Fabricação de outros produtos químicos não especificados anteriormente CÓDIGO E DESCRIÇÃO DAS ATIVIDADES ECONÔMICAS SECUNDÁRIAS 46.79-6-01 - Comércio atacadista de tintas, vernizes e similares 46.84-2-99 - Comércio atacadista de outros produtos químicos e petroquímicos não especificados anteriormente 46.63-0-00 - Comércio atacadista de Máquinas e equipamentos para uso industrial; partes e peças 28.66-6-00 - Fabricação de máquinas e equipamentos para a indústria do plástico, peças e acessórios 82.11-3-00 - Serviços combinados de escritório e apoio administrativo 64.63-8-00 - Outras sociedades de participação, exceto holdings 71.20-1-00 - Testes e análises técnicas 22.29-3-02 - Fabricação de artefatos de material plástico para usos industriais CÓDIGO E DESCRIÇÃO DA NATUREZA JURÍDICA 206-2 - Sociedade Empresária Limitada LOGRADOURO AV FRANCISCO NAKASATO NÚMERO 1700 COMPLEMENTO ******** CEP 13.295-000 BAIRRO/DISTRITO SAO ROQUE DA CHAVE MUNICÍPIO ITUPEVA UF SP ENDEREÇO ELETRÔNICO FABIANA.SILVA@POLYONE.COM TELEFONE (11) 4593-9279/ (11) 4593-9252 ENTE FEDERATIVO RESPONSÁVEL (EFR) ***** SITUAÇÃO CADASTRAL ATIVA DATA DA SITUAÇÃO CADASTRAL 08/04/2005 MOTIVO DE SITUAÇÃO CADASTRAL SITUAÇÃO ESPECIAL ******** DATA DA SITUAÇÃO ESPECIAL ******** Aprovado pela Instrução Normativa RFB nº 1.863, de 27 de dezembro de 2018.